Germany Vaccine Packaging Market Size, Share, and COVID-19 Impact Analysis, By Material (Glass and Plastic), By Application (Vaccine Manufacturers and Healthcare Providers), and Germany Vaccine Packaging Market Industry Trend, Forecasts to 2035

Industry: Chemicals & Materials

RELEASE DATE Sep 2025
REPORT ID SI15733
PAGES 217
REPORT FORMAT PathSoft

Germany Vaccine Packaging Market Insights Forecasts to 2035

  • The Germany Vaccine Packaging Market Size Was Estimated at USD 84.48 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 8.92% from 2025 to 2035
  • The Germany Vaccine Packaging Market Size is Expected to Reach USD 216.32 Million by 2035

 

Germany Vaccine Packaging Market

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights & Consulting, The Germany Vaccine Packaging Market Size is anticipated to reach USD 216.32 Million by 2035, growing at a CAGR of 8.92% from 2025 to 2035. The demand for vaccine packaging is growing globally due to a combination of public health priorities, advances in biotechnology, and the rising frequency of epidemic and pandemic outbreaks.

 

Market Overview

The vaccine packaging market encompasses the provision and development of materials and containers, including vials, ampoules, or syringes, for the stabilization, sterilization, and transport of vaccines. Stability, sterility, and efficacy throughout the supply chain are critical, as vaccines must be protected against heat, moisture, or other challenges and remain stable without losing efficacy when transported to a healthcare setting or citizen. As countries recognize the importance vaccines play in global health, interest and uptake of vaccines can only be expected to increase. In concert with the benefits of safety and efficacy, innovations in vaccines will change vaccine administration and storage requirements. Advancements in an array of vaccine administration, such as new multi-dose products and/or via various devices, are evidence of the type of accelerated change the veterinary and pharmaceutical industries are working on. There are a number of options in packaging; with the expected changes in healthcare and vaccines, the product offerings into the marketplace are significant areas for growth. The market still offers opportunities for growth relating to cold-chain technology, sustainable packaging, or smart labeling.

 

Report Coverage

This research report categorizes the market for Germany vaccine packaging market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Germany vaccine packaging market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment Germany vaccine packaging market.

 

Germany Vaccine Packaging Market Report Coverage

Report CoverageDetails
Base Year:2021
Market Size in 2021:USD 84.48 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :8.92%
2035 Value Projection:USD 216.32 Million
Historical Data for:2020-2023
No. of Pages:217
Tables, Charts & Figures:120
Segments covered:By Material and By Application
Companies covered:: Schott AG, Gerresheimer AG, Dedecke, August Faller GmbH & Co. KG, Wacker Chemie AG, CordenPharma, Celonic AG, IDT Biologika, BioNTech SE, Vetter Pharma International, Rentschler Biopharma SE, and Others
Pitfalls & Challenges:COVID-19 Empact, Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The expanding vaccination initiatives worldwide, increasing incidence of infectious disease, and emerging vaccine technologies, such as mRNA and recombinant vaccines, require a high degree of stability and sterility. These developments lead to increased demand for materials like glass and specialty plastics.

 

Restraining Factors

Limited access to pharmaceutical-grade glass can postpone production and distribution schedules that are already strained in the supply chain. Lastly, the regulatory framework/market access process and the quality control aspect of biopharmaceuticals are rigorous, taking time and money to penetrate the market.

 

Market Segmentation

The Germany vaccine packaging market share is classified into material and application.

 

  • The glass segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Germany vaccine packaging market is segmented by material into glass and plastic. Among these, the glass segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. Its superior chemical stability, impermeability, and compatibility with sensitive biologics. Glass vials and ampoules are preferred for maintaining vaccine integrity, especially in mRNA and live-attenuated formulations. Rising vaccination programs and stringent regulatory standards also support glass use.

 

  • The vaccine manufacturers segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Germany vaccine packaging market is segmented by application into vaccine manufacturers and healthcare providers. Among these, the vaccine manufacturers segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period. The increased vaccine production driven by public health initiatives and pandemic preparedness. Manufacturers require high-quality, sterile, and durable packaging materials like glass vials to ensure vaccine safety and stability during storage and transport. Additionally, advancements in vaccine technologies, such as mRNA-based vaccines, demand specialized packaging solutions.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Germany vaccine packaging market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Schott AG
  • Gerresheimer AG
  • Dedecke
  • August Faller GmbH & Co. KG
  • Wacker Chemie AG
  • CordenPharma
  • Celonic AG
  • IDT Biologika
  • BioNTech SE
  • Vetter Pharma International
  • Rentschler Biopharma SE
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at Germany, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Germany vaccine packaging market based on the below-mentioned segments:

 

Germany Vaccine Packaging Market, By Material

  • Glass
  • Plastic

 

Germany Vaccine Packaging Market, By Application

  • Vaccine Manufacturers
  • Healthcare providers

Frequently Asked Questions (FAQ)

  • Q.1: What is the market size of the Germany Vaccine Packaging Market in 2024?
    A: The Germany Vaccine Packaging Market size was estimated USD 84.48 Million in 2024.
  • Q.2: What is the forecasted CAGR of the Germany Vaccine Packaging Market from 2024 to 2035?
    A: The market is expected to grow at a CAGR of around 8.92% during the period 2024–2030.
  • Q.3: Who are the top 10 companies operating in the Germany Vaccine Packaging Market?
    A: Key players include Schott AG, Gerresheimer AG, Dedecke, August Faller GmbH & Co. KG, Wacker Chemie AG, CordenPharma, Celonic AG, IDT Biologika, BioNTech SE, Vetter Pharma International, Rentschler Biopharma SE
  • Q.4: What are the main drivers of growth in the Germany Vaccine Packaging Market?
    A: The expanding vaccination initiatives worldwide, increasing incidence of infectious disease, and emerging vaccine technologies, such as mRNA and recombinant vaccines, require a high degree of stability and sterility.
  • Q.5: What is the main restraining of growth in the Germany Vaccine Packaging Market?
    A: Limited access to pharmaceutical-grade glass can postpone production and distribution schedules that are already strained in the supply chain.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies